| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Giannella Alvarez last filed a Form 4 in May 2024, as Director at TCNNF. Giannella Alvarez's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 44,732 shares of TCNNF. The TCNNF filings lean toward selling, a net 1,072 shares.
Giannella Alvarez has 6 Form 4 filings on record from October 2021 to May 2024, all as Director at Trulieve Cannabis (TCNNF), 2021–2024.
The 12 reported transactions were 4 option or other derivative awards, 3 stock awards, 2 option exercises and 2 dispositions back to the company, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $14K.
The only open-market sale was 1,072 shares of TCNNF at an average $12.76 on May 16, 2024, about $14K.
Shares as reported in the last Form 4 for each company; the most recent is from May 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 16, 2024 | TCNNF Trulieve Cannabis Corp. | Director | Sell | 1,072 | $12.76 | $13,677.54 | -2.3% |